Each semester, a colloquium series is organized by the Institute for Biotechnology to expose the students in the program to prominent speakers from the academic and industrial settings. The colloquium series is open to all and is typically attended by members of the Institute for Biotechnology as well as the students and faculty from St. John’s College and the College of Pharmacy and Health Sciences. The colloquium series serves as an excellent opportunity for networking while learning about various facets of research in Biotechnology and its interdisciplinary nature.

Fall 2012

Dr. Niven Narain - Wednesday, October 10, 2012
President & CTO - Berg Biosystems, Natick, MA
“Interrogative biology: A novel platform for the engagement of biointelligence and
drug discovery”

Dr. Renuka Pillutla - Wednesday, November 14, 2012
Associate Director – Bioanalytical  Sciences, Biologics Bristol-Myers Squibb, Princeton, NJ
“Immunogenicity Testing of Biotherapeutics”

Dr. Dana Ferraris - Wednesday, December 5, 2012
Principal Scientist – Brain Science Institute Johns Hopkins University, Baltimore, MD
“Poly (ADP-ribose) Polymerases (PARPs) as therapeutic targets”

Spring 2012

Dr. Prem Premsrirut -Wednesday, February 8, 2012
President and CEO,  Mirimus Inc., Cold Spring Harbor, NY
“RNAi mouse models for target discovery, validation and toxicology assessment'’

Dr. Phil Lukeman -Wednesday, March 14, 2012
Associate Professor of Organic Chemistry, Department of Chemistry, St. John’s University, NY
“Nanochemistry for Noobs: Nanodoodads built by Novices from Nucleic Acids”

Dr. Ray Huang -Wednesday, April 18, 2012
Founder and President , RayBiotech Inc., Norcross, GA
“Accelerated biomedical discovery using protein and antibody array techniques”

Fall 2011

Dr. Lesley Davenport - Wednesday, September 21, 2011
Professor and Deputy Chair, Department of Chemistry, Brooklyn College of the
City University of New York, NY
“DNA  Knots and Tumorigenesis: Folding and Conformation of Quadruplex-DNA'’

Dr. Paul Naylor - Wednesday, November 2, 2011
Director Cytokine Biology, IRX Therapeutics, Farmingdale, NY
“IRX-2-A Novel Pleotropic Immune Modulator for Cancer Therapy”

Dr. Simon Geir Møller - Wednesday, November 30, 2011
Professor and EMBO Young Investigator, Department of Biological Sciences, St John's University, NY
“Iron-Sulfur Clusters and Parkinson’s Disease: Using Multiple Models to answer
Complex questions”